Literature DB >> 15380258

The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.

D T Tsukayama1, H J van Loon, C Cartwright, B Chmielewski, A C Fluit, Chr van der Werken, J Verhoef.   

Abstract

Bacterial spread between patients may contribute to the high prevalence of antibiotic-resistant pathogens within ICUs. The aim of this study was to evaluate the fate of Pseudomonas aeruginosa during the different antibiotic regimens. Susceptibility patterns and genotyping were performed to determine whether there was a predominant clone and to track the spread of resistant strains within the unit. Twenty-eight different ribotypes were found among 82 Pseudomonas isolates. Four ribotypes accounted for 42 (51%) isolates and were designated the "major clones" occurring throughout multiple cycles. The ribotypes with multiple occurrences were more resistant to antibiotics than ribotypes that appeared only once. The correlation of antibiotic use with antibiotic resistance and the finding of a large number of ribotypes suggested that de novo development of antibiotic resistance is a likely event in P. aeruginosa. In addition, ribotypes associated with antibiotic resistance appeared to have a survival advantage and can become frequent colonizers in the ICU.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380258     DOI: 10.1016/j.ijantimicag.2004.04.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

1.  Bacterial isolates from equine infections in western Canada (1998-2003).

Authors:  Chris Clark; Sarah Greenwood; Joe O Boison; Manuel Chirino-Trejo; Patricia M Dowling
Journal:  Can Vet J       Date:  2008-02       Impact factor: 1.008

2.  Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.

Authors:  Noha A Hassuna
Journal:  Surg Infect (Larchmt)       Date:  2016-07-21       Impact factor: 2.150

3.  Impact of a Multimodal Antimicrobial Stewardship Program on Pseudomonas aeruginosa Susceptibility and Antimicrobial Use in the Intensive Care Unit Setting.

Authors:  Douglas Slain; Arif R Sarwari; Karen O Petros; Richard L McKnight; Renee B Sager; Charles J Mullett; Alison Wilson; John G Thomas; Kathryn Moffett; H Carlton Palmer; Harakh V Dedhia
Journal:  Crit Care Res Pract       Date:  2011-05-19

4.  Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.

Authors:  Z Movahedi; B Pourakbari; S Mahmoudi; F Sabouni; M T Ashtiani Haghi; R Hosseinpour Sadeghi; S Mamishi
Journal:  J Prev Med Hyg       Date:  2013-03

5.  Effect of glutathione-stabilized silver nanoparticles on expression of las I and las R of the genes in Pseudomonas aeruginosa strains.

Authors:  Mina Pourmbarak Mahnaie; Hassan Mahmoudi
Journal:  Eur J Med Res       Date:  2020-05-20       Impact factor: 2.175

6.  Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings.

Authors:  Geraldine Mary Conlon-Bingham; Mamoon Aldeyab; Michael Scott; Mary Patricia Kearney; David Farren; Fiona Gilmore; James McElnay
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

7.  The role of Gene Mutations (gyrA, parC) in Resistance to Ciprofloxacin in Clinical Isolates of Pseudomonas Aeruginosa.

Authors:  Nasibeh Arabameri; Zoheir Heshmatipour; Shima Eftekhar Ardebili; Zeinab Jafari Bidhendi
Journal:  Iran J Pathol       Date:  2021-07-06

8.  Multidrug-resistant Pseudomonas aeruginosa is predisposed to lasR mutation through up-regulated activity of efflux pumps in non-cystic fibrosis bronchiectasis patients.

Authors:  Fengming Ding; Lei Han; Yishu Xue; Iris Tingshiuan Yang; Xinxin Fan; Rong Tang; Chen Zhang; Miao Zhu; Xue Tian; Ping Shao; Min Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

9.  Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Iranian Hospital Infections.

Authors:  Nastaran Fazeli; Hassan Momtaz
Journal:  Iran Red Crescent Med J       Date:  2014-10-05       Impact factor: 0.611

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.